Y. Inoue

SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer.

I. Thompson, C. Tangen, N. Agarwal, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy--a randomized controlled trial.

N. Tajima, M. Matsushima, S. Katoh, 2001, Metabolism: clinical and experimental.

[Doses of epirubicin used in oily chemoembolization of hepatocellular carcinoma].

S. Hori, K. Tomoda, H. Nakamura, 1994, Gan to kagaku ryoho. Cancer & chemotherapy.

Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.

B. Basnyat, Jeffrey H. Gertsch, E. W. Johnson, 2003, High altitude medicine & biology.

A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma

N. Burwick, P. Becker, W. Bensinger, 2016, Blood Cancer Journal.

Effects of amsacrine in combination with other anticancer agents in human acute lymphoblastic leukemia cells in culture.

Y. Miura, T. Kasahara, Y. Kano, 1991, Leukemia research.

Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamide.

E. Yu, A. Cowan, Y. Inoue, 2015, Clinical genitourinary cancer.

Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro.

K. Adachi, J. Matsui, Y. Kano, 1996, British Journal of Cancer.

A Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy In Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Leukemia (SLL)

D. Maloney, J. Pagel, S. Petersdorf, 2013 .

SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer.

C. Tangen, N. Agarwal, E. Lam, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.